REG - Target H'care REIT - Admission, share capital and total voting rights

Target Healthcare ReitAnnouncement

27/09/2019 15:50

RNS Number : 0162O
Target Healthcare REIT PLC
27 September 2019
 


Target Healthcare REIT plc
Admission, share capital and total voting rights
Following the announcement on 26 September 2019, 72,398,191 new ordinary shares will be admitted to the premium segment of the official list of the Financial Conduct Authority ("FCA") and to trading on the main market of the London Stock Exchange with effect from 8.00 a.m. on Monday 30 September ("Admission").
As explained in the Prospectus published by the Company on 21 June 2019, the Company applied to the High Court of England and Wales (the "Court") to reduce the nominal value of its ordinary shares from £1.00 to £0.01 per ordinary share (the "Reduction"). The Directors are pleased to announce that the Court has confirmed the Reduction and the Court's order has been registered by the Registrar of Companies. The Reduction is effective and the Company's issued share capital therefore, following the Reduction and Admission, will consist of 457,487,640 ordinary shares of £0.01 each. The total number of voting rights of the Company will be 457,487,640 and this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.
For information purposes, the trading details in relation to the Company's ordinary shares are as follows:
TIDM:      THRL
ISIN:       GB00BJGTLF51
SEDOL:  BJGTLF5
LEI:         213800RXPY9WULUSBC04
Enquiries:
 
Target Fund Managers Limited (Investment Manager to the Company)                                            



Kenneth MacKenzie






+44 1786 845 912




Gordon Bland
 






+44 1786 845 920




Stifel Nicolaus Europe Limited












Mark Young


mark.young@stifel.com


+44 20 7710 7600




Tom Yeadon


tom.yeadon@stifel.com


+44 20 7710 7600




Neil Winward


neil.winward@stifel.com


+44 20 7710 7600


















FTI Consulting


TargetHealthcare@fticonsulting.com


+44 20 3727 1000




Dido Laurimore












Claire Turvey












Richard Gotla











 
Notes:
 
A copy of this announcement will be available on the Company's website.
 
 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCBSGDCXSDBGCR